Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature

By Mahil SATVEER K.  

Journal of Dermatological Treatment, Vol. 24, Iss. 1, 2013-02 ,pp. : 38-49

Informa Healthcare

Access to resources Recommend Favorite

Lack of Anti-drug Antibodies in Patients with Psoriasis Well-controlled on Long-term Treatment with Tumour Necrosis Factor Inhibitors

By Meyer Martin W.   Zachariae Claus   Bendtzen Klaus   Skov Lone  

Acta Dermato-Venereologica, Vol. 92, Iss. 4, 2012-07 ,pp. : 362-364

Medical Journals Limited

Access to resources Recommend Favorite

Discontinuation of Methotrexate in Psoriasis

By Due Eva   Blomberg Maria   Skov Lone   Zachariae Claus  

Acta Dermato-Venereologica, Vol. 92, Iss. 4, 2012-07 ,pp. : 353-354

Medical Journals Limited

Access to resources Recommend Favorite

Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors: An Update on Infliximab

By Brunasso Alexandra Maria Giovanna   Massone Cesare  

Acta Dermato-Venereologica, Vol. 91, Iss. 1, 2011-01 ,pp. : 70-71

Medical Journals Limited

Access to resources Recommend Favorite

Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-α Inhibitors

By Haslund Pia   Lee Robert A.   Jemec Gregor B. E.  

Acta Dermato-Venereologica, Vol. 89, Iss. 6, 2009-10 ,pp. : 595-600

Medical Journals Limited

Access to resources Recommend Favorite